Avanish Vellanki

Insider Reports History

Location
Newark, CA
Signature
/s/ Ryan Murr, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Avanish Vellanki:

Company Role Class Num Shares Value Price $ Report Date Ownership
Rain Oncology Inc. Chairman and CEO, Director Common Stock, par value $0.001 per share 0 $0 $1.21 26 Jan 2024 Direct
Rain Oncology Inc. Chairman and CEO, Director Stock Option (Right to Buy) 0 26 Jan 2024 Direct

Insider Reports Filed by Avanish Vellanki

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000199937124000956-vellanki-avanish-2024-01-26 Rain Oncology Inc. 26 Jan 2024 8 $0 4 Chairman and CEO, Director 26 Jan 2024, 16:34
/report/000110465923090706-vellanki-avanish-2023-08-09 Rain Oncology Inc. 09 Aug 2023 2 $0 4 Chairman and CEO, Director 11 Aug 2023, 21:17
/report/000110465923023386-vellanki-avanish-2023-02-15 Rain Oncology Inc. 15 Feb 2023 1 $0 4 Chairman and CEO, Director 17 Feb 2023, 17:15
/report/000089924322020666-vellanki-avanish-2022-06-01 Rain Therapeutics Inc. 01 Jun 2022 1 +$57,250 4 Chairman and CEO, Director, 10%+ Owner 02 Jun 2022, 16:05
/report/000089924322014885-vellanki-avanish-2022-04-14 Rain Therapeutics Inc. 14 Apr 2022 2 $0 4 Chairman and CEO, Director, 10%+ Owner 15 Apr 2022, 16:30
/report/000089924322011033-vellanki-avanish-2022-03-11 Rain Therapeutics Inc. 11 Mar 2022 2 +$57,872 4 President and CEO, Director 15 Mar 2022, 15:23
/report/000089924322004830-vellanki-avanish-2022-02-02 Rain Therapeutics Inc. 02 Feb 2022 1 $0 4 President and CEO, Director 04 Feb 2022, 15:30